ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $882,130 | -47.5% | 28,465 | -56.8% | 0.01% | -54.5% |
| Q3 2022 | $1,679,000 | +12.8% | 65,834 | -10.2% | 0.01% | +22.2% |
| Q2 2022 | $1,488,000 | -23.3% | 73,278 | -6.6% | 0.01% | -10.0% |
| Q1 2022 | $1,940,000 | -36.6% | 78,427 | -10.9% | 0.01% | -33.3% |
| Q4 2021 | $3,060,000 | +28.4% | 88,069 | +0.2% | 0.02% | +25.0% |
| Q3 2021 | $2,383,000 | +14.7% | 87,882 | +9.6% | 0.01% | +9.1% |
| Q2 2021 | $2,078,000 | +22.7% | 80,149 | +1.9% | 0.01% | +22.2% |
| Q1 2021 | $1,694,000 | +4.2% | 78,617 | +4.0% | 0.01% | -10.0% |
| Q4 2020 | $1,626,000 | +26.0% | 75,617 | -13.5% | 0.01% | +11.1% |
| Q3 2020 | $1,290,000 | -45.9% | 87,451 | -18.1% | 0.01% | -47.1% |
| Q2 2020 | $2,386,000 | +55.0% | 106,791 | -1.9% | 0.02% | +21.4% |
| Q1 2020 | $1,539,000 | +4.9% | 108,900 | +20.6% | 0.01% | +40.0% |
| Q4 2019 | $1,467,000 | – | 90,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |